# Hongfei Jia

> Hongfei Jia is a startup investor at Fosun Pharma. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Fosun Pharma](https://shizune.co/investors/profile/fosun-pharmaceutical)
- Last updated: Aug 2026

Hongfei Jia is a startup investor at Fosun Pharma. HONGFEI JIA is Senior Vice President, Joint Chief Investment Officer, Chairman of Medical Devices Division, and General Manager of International Operations Department of Shanghai Fosun Pharmaceutical (Group) Co., Ltd..Born in 1967, he is a Canadian and holds a Master’s Degree of Business Administration. From 1989 to 2012, he successively workedfor Gillette Company and Audit Department of NCH U.S., and served as Financial Budget Planning Manager of Sino-American (Tianjin) Pharmaceutical Co., Ltd., Financial Manager of Glaxo Wellcome (China) Co., Ltd., Financial Manager of SAMTACK COMPUTER INC., Finance Director of Achieve Global, Vice General Manager & Finance Director of Simon Company, CFO of Jing Rui Real Estate (Group) Company and Finance Director of Goodbaby Group International Holdings Co., Ltd.

## About Fosun Pharma

VC Fund · Shanghai, China

Fosun Pharma is a biopharmaceutical and healthcare industry. Fosun Pharma has captured opportunities within the rapidly developing Chinese healthcare industry as well as from the globalization of Chinese healthcare companies in general. Fosun Pharma's operations strategically cover several important segments of the healthcare industryvalue-chain, including: pharmaceutical manufacturing, distribution and retail.

5 contacts available at Fosun Pharma.

| Name | Title | Profile |
| --- | --- | --- |
| Cui Zhiping | Vice President and General Manager of VC Investment Department | https://shizune.co/investors/profile/cui-zhiping |
| Hongfei Jia | SVP, Joint Chief Investment Officer and General Manager of International Operations Department | https://shizune.co/investors/profile/hongfei-jia |
| Wai Danny | Independent Non-Executive Director | https://shizune.co/investors/profile/wai-danny |
| Wu Yifang | Senior vice president and Chief operating officer | https://shizune.co/investors/profile/wu-yifang |
| Zhou Biao | SVP, General Manager of Legal Department and General Manager of Independent Inspectors Department | https://shizune.co/investors/profile/zhou-biao |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co